TD Waterhouse Canada’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.65K | Hold |
30
| – | – | ﹤0.01% | 1461 |
|
|
2025
Q1 | $7.64K | Hold |
30
| – | – | ﹤0.01% | 1455 |
|
|
2024
Q4 | $7.06K | Hold |
30
| – | – | ﹤0.01% | 1479 |
|
|
2024
Q3 | $8.26K | Sell |
30
-806
| -96% | -$222K | ﹤0.01% | 1395 |
|
|
2024
Q2 | $203K | Sell |
836
-9
| -1% | -$2.19K | ﹤0.01% | 764 |
|
|
2024
Q1 | $131K | Buy |
845
+31
| +4% | +$4.8K | ﹤0.01% | 848 |
|
|
2023
Q4 | $159K | Sell |
814
-26
| -3% | -$5.08K | ﹤0.01% | 721 |
|
|
2023
Q3 | $154K | Sell |
840
-50
| -6% | -$9.17K | ﹤0.01% | 684 |
|
|
2023
Q2 | $172K | Sell |
890
-41
| -4% | -$7.92K | ﹤0.01% | 686 |
|
|
2023
Q1 | $191K | Sell |
931
-4
| -0.4% | -$819 | ﹤0.01% | 660 |
|
|
2022
Q4 | $223K | Sell |
935
-199
| -18% | -$47.5K | ﹤0.01% | 632 |
|
|
2022
Q3 | $227K | Sell |
1,134
-1,678
| -60% | -$335K | ﹤0.01% | 646 |
|
|
2022
Q2 | $422K | Sell |
2,812
-35
| -1% | -$5.26K | ﹤0.01% | 576 |
|
|
2022
Q1 | $489K | Sell |
2,847
-29
| -1% | -$4.98K | ﹤0.01% | 595 |
|
|
2021
Q4 | $482K | Buy |
+2,876
| New | +$482K | ﹤0.01% | 614 |
|